Document is current
Any future updates will be listed below
-
Authors
Loft, Anne https://orcid.org/0000-0002-5647-8295
Rydbirk, Rasmus https://orcid.org/0000-0002-4670-7533
Klinggaard, Ellen Gammelmark https://orcid.org/0000-0003-1486-5219
Van Hauwaert, Elvira Laila
Wernberg, Charlotte Wilhelmina https://orcid.org/0000-0001-8964-0650
Møller, Andreas Fønss https://orcid.org/0000-0002-4073-5568
Dam, Trine Vestergaard https://orcid.org/0000-0003-1148-0591
Hassan, Mohamed Nabil
Maniyadath, Babukrishna
Nielsen, Ronni
Krag, Aleksander
Kalucka, Joanna https://orcid.org/0000-0003-4887-7672
Schmidt, Søren Fisker
Lauridsen, Mette Enok Munk https://orcid.org/0000-0003-0586-8549
Madsen, Jesper Grud Skat https://orcid.org/0000-0002-0518-0800
Mandrup, Susanne https://orcid.org/0000-0002-0961-5787
-
Funding
Funding for this research was provided by:
Novo Nordisk Fonden (NNF18OC0033444)
Novo Nordisk Fonden (NNF21SA0072102)
Danmarks Grundforskningsfond (Project grant: 141)
Danmarks Grundforskningsfond (Project grant: 141)
Danmarks Grundforskningsfond (Project grant: 141)
Lundbeckfonden (R413-2022-471)
- License Information
-
More Information
Article History
Received: 26 December 2024
Accepted: 24 November 2025
First Online: 12 January 2026
Competing interests
: A.K. has served as a speaker for Novo Nordisk, Norgine Danmark and participated in advisory boards for Boehringer Ingelheim, GSK and Novo Nordisk, all outside the submitted work. A.K. received funding from Astra, Siemens, Nordic Bioscience and Echosense. A.K. is a board member and co-founder Evido. The other authors declare no competing interests.
